Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis.
Tumor lysis syndrome has rarely been observed in solid tumors. We report a case of a patient with advanced invasive thymoma associated with peripheral blood T-cell lymphocytosis in whom tumor lysis syndrome developed after chemotherapy. The potential for tumor lysis syndrome should be anticipated when treating extensive thymoma.
Yokoi
K
K
Division of Thoracic Diseases, Tochigi Cancer Center, Utsunomiya, Japan.
Miyazawa
N
N
Kano
Y
Y
Akutsu
M
M
Mori
K
K
Tominaga
K
K
Imura
G
G
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D016130:Immunophenotyping; D008218:Lymphocytosis; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D009361:Neoplasm Invasiveness; D011239:Prednisolone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D013601:T-Lymphocytes; D013899:Thoracic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000532:radiotherapy / Q000556:secondary*; D013945:Thymoma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D002945:Cisplatin; D008775:Methylprednisolone